Skip to main content
. 2022 Apr 4;22:332. doi: 10.1186/s12879-022-07313-6

Table 1.

Basic information of study participants, January 2013 to June 2017

Participants
(n = 3,987,573)
P value*
Sex distribution of population, n (%)
 Male 1,906,485 (47.81)
 Female 2,081,088 (52.19)
Urban–rural distribution of population, n (%)
 Urban 2,284,975 (57.30)
 Rural 1,702,598 (42.70)
Recruiting time (year), n (%)
 2013 3,017,631 (75.67)
 2014 338,850 (8.50)
 2015 332,129 (8.33)
 2016 214,279 (5.37)
 2017 84,684 (2.12)
Case number of infectious diseases (incidence density, per 100,000 person–years)
 Total 106,289 (694.86) < 0.0001
 Notifiable infections 73,801 (482.47) < 0.0001
 Non–notifiable infections 32,488 (212.39) < 0.0001
Case number of five categories of infectious diseases (incidence density, per 100,000 person–years)
 Respiratory 61,951 (405.00) < 0.0001
 Gastrointestinal 9862 (64.47) < 0.0001
 Vector–borne 1128 (7.37) < 0.0001
 Blood– and sexually transmitted 10,170 (66.48) < 0.0001
 Mucocutaneous 23,178 (151.52) < 0.0001
Annual case number of infectious diseases (incidence density, per 100,000 person–years)
 2013 10,313 (364.81)
 2014 12,813 (397.04)
 2015 27,181 (771.20)
 2016 35,167 (931.37)
 2017 20,815 (1071.80)

*Calculated by χ² test for trend from 2013 to 2017